NoArc: Nonoperative Treatment of Acute Achilles Tendor Rupture

Sponsor
Central Finland Hospital District (Other)
Overall Status
Recruiting
CT.gov ID
NCT03704532
Collaborator
University of Jyvaskyla (Other)
200
1
77
2.6

Study Details

Study Description

Brief Summary

A prospective, non-randomised, observational study to investigate the clinical and biomechanical outcomes and prevalence of reruptures after operative or nonoperative treatment of acute achilles tendon rupture.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Operative treatment
  • Procedure: Nonoperative treatment

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Nonoperative Treatment of Acute Achilles Tendor Rupture in Central Finland: Prospective Cohort Study
Actual Study Start Date :
Apr 1, 2017
Anticipated Primary Completion Date :
Aug 31, 2021
Anticipated Study Completion Date :
Aug 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Operative treatment

Patients having undergone an operative treatment of achilles tendon rupture

Procedure: Operative treatment
Open surgical repair of tendon rupture

Nonoperative treatment

Patients having undergone a nonoperative treatment with functional rehabilitation of achilles tendon rupture

Procedure: Nonoperative treatment
Nonoperative treatment with lower leg orthosis and functional rehabilitation

Outcome Measures

Primary Outcome Measures

  1. Rerupture rate [1 year]

    Rate rerupture of a healed tendon after the end of the intervention

Secondary Outcome Measures

  1. Physical Activity Level [1 year]

    Patient activity 1 year after the rupture using the Tegner activity level scale which varies from 0 to 10. This scale that aims to provide a standardized method of grading work and sporting activities.

  2. University of California, Los Angeles (UCLA) score [1 year]

    Patient activity 1 year after the rupture

  3. Achilles tendon rupture score (ATRS) [1 year]

    Achilles tendon rupture score 1 year after the rupture

  4. Functional Score [1 year]

    Leppilahti score measuring subjective and objective functional outcome 1 year after the rupture on a scale 0-100.

  5. Foot inversion [1 year]

    Foot inversion angle in rest

  6. Foot flexion-extension [1 year]

    Foot flexion-extension angle in rest

  7. Heel-raise test [1 year]

    One leg heel-raise test while standing

Other Outcome Measures

  1. Muscle strength [1 year]

    Isometric plantar flexion strength

  2. Gastrocnemius muscle cross-sectional area [1 year]

    Lateral and medial gastrocnemius and soleus muscle area using ultrasound

  3. Tendon length [1 year]

    Achilles tendon length using ultrasound

  4. Research ANd Development (RAND-36) quality of life [1 year]

    Measurement of quality of life using RAND-36 questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • acute achilles tendon rupture with clear onset of symptoms

  • closed rupture

  • resides in the catchment area of our hospital district

Exclusion Criteria:
  • avulsion fractures in the calcaneus

  • unwillingness to participate

  • inability to communicate using Finnish language

Contacts and Locations

Locations

Site City State Country Postal Code
1 Central Finland Hospital Jyväskylä Keski-Suomi Finland 40620

Sponsors and Collaborators

  • Central Finland Hospital District
  • University of Jyvaskyla

Investigators

  • Study Chair: Juha Paloneva, MD, PhD, Central Finland Health Care District

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Central Finland Hospital District
ClinicalTrials.gov Identifier:
NCT03704532
Other Study ID Numbers:
  • 2U/2018
First Posted:
Oct 12, 2018
Last Update Posted:
Aug 13, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Central Finland Hospital District
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 13, 2021